

Notes:
Volume 6, Issue 4 (Suppl)
Clin Pharmacol Biopharm, an open access journal
ISSN: 2167-065X
Page 62
Euro Biopharma & Ethnopharmacology 2017
November 09-11, 2017
&
6
th
International Conference and Exhibition on
November 09-11, 2017 Vienna, Austria
4
th
EUROPEAN BIOPHARMA CONGRESS
PHARMACOLOGY AND ETHNOPHARMACOLOGY
Joint Event
Graphene oxide and photosensitizer interaction in drug delivery
Claure N Lunardi, Fellipy S Rocha
and
Anderson J Gomes
University of Brasília, Brazil
G
raphene Oxide (GO) is an oxidized form of graphene, containing functional groups exposed all over its surface expanding
the capacity to link drugs and other functional molecules through noncovalent/covalent interaction. Therefore, GO can
be considered an appropriate platform, since it can easily physically absorb cationic charged dye compounds via strong p-p and
electrostatic interaction on its surface resulting on the formation of GO-dye composite. GO is basically composed of carbon
than it can be considered relatively biocompatible, being a suitable candidate for biological applications as well. We associated
GO with a photosensitizer for photodynamic therapy. UV-vis spectroscopy and fluorescence emission measurement were used
to characterize this system.
Biography
Claure N Lunardi has completed her Undergraduate in Chemistry from Universidade de São Paulo (1996), Master's at Chemistry from Universidade de São Paulo
(1999) and PhD at Chemistry from Universidade de São Paulo (2004). She has experience in Chemistry, focusing on Photochemistry and Nanotechnology. She
has published more than 45 papers in reputed journals.
clunardi@unb.brClaure N Lunardi et al., Clin Pharmacol Biopharm 2017, 6:4(Suppl)
DOI: 10.4172/2167-065X-C1-026